ATAD2 and neoplasm: ATAD2 has also been identified as a coactivator of hormone-induced nuclear receptors (oestrogen receptor alpha (ERα) and androgen receptor (AR)), E2Fs, and c-myc for the promotion of tumor progression [5, 11, 12].